Randomized trial evaluates medication use changes in cervical dystonia, suggesting a reduction in low-value care.
We evaluated the impact of onabotulinumtoxinA treatment on opioid, skeletal muscle relaxant (SMR), and benzodiazepine (BZD) use among patients diagnosed with cervical dystonia (CD) with prior use of these medications.
No takes yet. Share an insight, caveat, or question.
Jabbari et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: